American cutaneous leishmaniasis (ACL) is a disease where susceptibility or resistance is dependent on T cell response. This is characterized by an increased in CD4 + T cells, capable of inducing opposite disease profiles, and CD8 + T cells, that are related to immuno protection. We characterized T lymphocytes from patients before and after treatment, patients that spontaneously healed and controls, also evaluating their production of IL-10, IL-4, TNF-a and IFN-c, after stimulation with soluble/insoluble antigenic fractions of Leishmania (Viannia) braziliensis. We observed the production of suppressive cytokines in the early phase of leishmaniasis with significant presence CD4 + T cells, suggesting their connection with disease progression. After healing, the immune pattern observed was a type 1 response, what seems to be associated with cure and/or protection in the ACL. The results also showed that both fractions induced a specific immune response, contributing to the search for relevant antigens in this disease.
Introduction
Leishmaniasis is considered an emerging and re-emergent disease, with an increase in its incidence in the last decades [1] . It has a global estimated prevalence of 12 million cases, with an estimative of 1.5-2 million new cases each year. At the present moment leishmaniasis occurs in 88 countries throughout Europe, Africa, Asia and America, and 350 million people are at risk of contracting the disease [2, 3] .
The American cutaneous leishmaniasis (ACL) is caused by different species of the genus Leishmania, and Leishmania (Viannia) braziliensis is the prevalent etiologic agent in Latin America, being also the prevailing agent in the Northeast region of Brazil and in the state of Pernambuco [4, 5] . The clinical manifestations are broad and are determined by the species of leishmania, vector virulence factors and host immune response [3, 6] . The pathogenesis is related to the interactions between the host innate and adaptive immune system, as well as the nutritional status and genetic factors. The disease may vary from asymptomatic forms to cutaneous and mucocutaneous ones [1, 3, 6] .
In all ACL clinical forms, T lymphocytes are critical for cure and generation of a protective immune response, also being responsible for the disease persistence and pathology [7] [8] [9] . CD4 + and CD8 + T cells act producing biologically relevant cytokines for the activation of monocytes and macrophage. In human leishmaniasis, the type 1 immune response, with the production of IFN-c, TNF-a and IL-12, has been associated with the infection control, by macrophage activation and parasite destruction [1, 3] . On the other hand, cytokines like IL-4, IL-10 and TGF-b, considered of type 2, favor parasite multiplication, inhibiting NO production by IFN-c activated macrophages [6, 7, 10] . These cytokines are also able to inhibit T cell differentiation into a type 1 profile and the subsequent production of IFN-c and TNF-a [11] . Therefore, the quality of the immune response can influence disease susceptibility and development, with specific activation of T cells (especially multifunctional T cells) contributing to it [12] . However, even though there are studies that helped to clarify the immune mechanisms of disease development and pathology, no clear data is available about what immune response is necessary to control the disease and what is the difference between patients that develop the disease and achieve clinical cure (with or without treatment). We examined in this study the CD4 + and CD8 + balance ex vivo and in vivo, and also the intracellular cytokine profile in patients' cells after stimulation with the soluble and insoluble L. (V.) braziliensis antigenic fractions. The differences in the immune response and profile of patients before and after treatment, and also of individuals with lesions that spontaneously healed, were investigated together with the capacity of our antigens to elicit it, helping in the development of future vaccines and immunotherapies.
Methods

Study group
The patients of the present study were from different endemic municipalities of Pernambuco, Brazil. Seventeen patients were selected before treatment (BT), with a disease evolution around 1.6 months; 11 of them returned 6 months after treatment (PT) and 5 were patients that spontaneously healed (SH). The selection of these individuals was based on criteria such as: being more than 12 years old, having confirmed diagnosis by the CPqAM/FIOCRUZ Leishmaniasis Referee Center, being active lesion carriers when BT patients or having re-epithelized characteristic lesions (scars) when PT and SH patients. The test results of the study group are summarized in Table 1 .
Patients selected before treatment were submitted to blood collection prior to chemotherapy treatment with Glucantime Ò (Sanofi-Aventis, Suzano, SP, Brazil). Patients that returned after treatment and that spontaneously healed had their blood collected after cicatrization of their lesions. Ten healthy individuals (CT) represented the control group from non endemic areas and without previous ACL infection. All of them signed the ''Term of Free and Informed Consent''. The CPqAM/FIOCRUZ Research Ethics Committee, Recife, Brazil approved the experimental protocols.
Leishmania antigenic fractions
Promastigote forms of L. (V.) braziliensis (MHOM/BR/75/M2903), cultured in vitro, were expanded in Schneider's medium (Sigma, St. Louis, MO) supplemented with 10% of fetal calf serum (Cultilab, Campinas, SP, Brazil) and 1% of antibiotics (100 UI/ml penicillin and 100 lg/ml streptomycin; Sigma, St. Louis, MO) until they reached the exponential phase. Afterwards, they were sedimented by centrifugation at 800Âg for 15 min at 4°C and three times washed with phosphate-buffered saline (PBS; pH 7.2). Proteases inhibitors such as 0.1 mM methyl-phenyl-fluoride and 2 mM ethylenediaminetetraacetic acid (Sigma, St. Louis, MO), pepstatin A 0.001 M (Sigma, St. Louis, MO), were added right after ultrasonicate (100 w/10 cycle/30 s with 2 pulses/s). The parasitic suspension was centrifuged at 10,000Âg for 10 min at 4°C. The resultant supernatant was removed and submitted to a new centrifugation at 100,000Âg for 1 h at the same temperature. The resultant supernatant was the soluble antigenic fraction (SOL), while the sediment was the insoluble antigenic fraction (INS). Both were submitted to protein determination according to Brito et al. [13] . The antigens were stored at À20°C until use.
Electrophoretic profile of soluble and insoluble antigens of L. (V.) braziliensis
The protein profile of the soluble and insoluble antigens of L. (V.) braziliensis were determined by a SDS (sodium dodecyl sulfate)-polyacrylamide gel electrophoresis. They presented proteins whose molecular weights varied between approximately 66 and 16 kDa compared to the standard molecular weight (Sigma, St. Louis, MO) ( Fig. 1) .
Obtaining the PBMC
Forty milliliters of peripheral blood in heparinized tube were collected, diluted in a proportion of 2:1 in PBS pH 7.2 and then added to a Ficoll-Hypaque (Amersham Biosciences, Uppsala, Sweden) gradient. After centrifugation at 400Âg for 30 min at 20°C a peripheral blood mononucleated cells (PBMCs) ring was obtained. The cells were washed twice with PBS pH 7.2 and submitted to centrifugation (300Âg for 15 min at 20°C). PBMCs were resuspended with RPMI 1640 medium (Cultilab, Campinas, SP, Brazil) supplemented with 10% of fetal calf serum (Cultilab, Campinas, SP, Brazil) and 1% antibiotic (100 UI/ml penicillin and 100 lg/ml streptomycin; Sigma, St. Louis, MO) and then counted in a Neubauer chamber using Trypan blue (Sigma, St. Louis, MO). The cells where then adjusted to a concentration of 4 Â 10 6 per tube/ml.
Cell culture and flow cytometry
PBMCs ( 
Peripheral blood immunophenotypic analysis
To determine the percentage of CD4 + and CD8 + T cells, 5 ml of peripheral blood were collected in tubes containing EDTA. Subsequently 100 ll blood aliquots were transferred to cytometry tubes containing monoclonal antibodies specific for the cell surface markers anti-CD4 or anti-CD8 conjugated with FITC (BD Bioscience, San Jose, CA) and incubated for 30 min. Afterwards, the samples were submitted to erythrocytes lysis, followed by 2 washes and centrifugations (7 min, 300Âg), with posterior resuspension in 400 ll of a 1% paraformaldehyde PBS solution. The cells immunophenotypic and morphometric parameters were determined by flow cytometry (FACSCalibur-BD, San Jose, CA) using the software CELLQuestPro™ (BD Bioscience, San Jose, CA) for acquisition and analysis of data (50,000 events/tube).
Analysis
The analyses were done first delimitating the lymphocytic region in a Forward Scatter (FSC) versus Side Scatter (SSC) graph. Based on this region the fluorescence graphs (FL1 Â FL2) were constructed, delimitating the quadrants for analyses. The quadrant limits were based on the negative population and previous antibodies titration. The values considered for the fluorescence analysis were the percentage of the quadrant region for each quadrant.
The statistical analyses were performed through SPSS 8.0 and GraphPad Prism 5.1, using nonparametric tests. For intragroup comparative analysis, the Kruskal-Wallis test was used and to detect differences between groups, the Mann-Whitney U-test, based on the two-tailed p value. The results were analyzed considering the value of p < 0.05 (statistically significant). (Fig. 2) .
Comparing the CD4/CD8 ratio in the ex vivo assays and in the PBMC cultures, we found a variation in the values presented by the groups. Patients BT, PT and SH in the ex vivo assays, as well BT cultures, showed a CD4/CD8 ratio >2, while SH patients in the ex vivo assays and the PT and SH after antigenic stimulation with the antigenic fractions showed a ratio <2 (Table 2 ).
Leishmania antigens induced different cytokine profiles, with a predominant Th2 profile in the beginning of infection and a Th1 one after therapy
The cellular source and frequency of cytokine-producing cells induced by antigenic fractions of L. (V.) braziliensis, were determined after culture. When the soluble and insoluble antigenic fractions were used, different profiles were observed. After stimulation with the antigens, CD8 + T cells were the main responsible for the production of IFN-c and TNF-a, the latter only in BT patients. (Fig. 3A and B).
Discussion
Human leishmaniasis infection resolution is dependent primarily on the events of T cell subtypes and cytokine production profile [9, 14] . However, the relationship of these mechanisms is still not well-established, especially in human L. (V.) braziliensis infections. In the present study we characterized patients before (BT) and after treatment (PT) and those that spontaneously healed (SH) immunophenotypically. Ex vivo and culture assays were performed, and we analyzed the cytokines produced in these cultures under in vitro stimulation with soluble or insoluble antigenic fractions of L. (V.) braziliensis-thereby characterizing and describing the specific immune response profile induced by these fractions.
PBMC cultures revealed a decrease in the CD4 + /CD8 + T cells ratio in patients BT compared to those PT. The SH patients had the lowest CD4 + /CD8 + T cells ratio, with a proportion of CD4 + T cells comparable to CT and a proportion of CD8 + T cells higher than patients PT and significant when compared with patients BT. CD4 + T cells are capable of inducing opposite disease developing profiles, depending on their cytokine production. Our results suggest their involvement in both the pathology and in its cure, as it has been observed by other groups [15, 16] . The CD8 + T cells have been involved in the control of ACL infection, and several authors have reported their increase in healed patients, suggesting its role by modulating the activity of CD4 + T cells, by direct cytolytic effect of macrophages infected, or even with regulatory effects [9, 15, [17] [18] [19] [20] . Our results confirm that a balance between the proportion of CD4 + and CD8 + T cells is important for lesion healing, a hypothesis also reinforced by others [15, 18, 20] .
It is important to highlight that the treatment with antimonials promotes a change in the host response to the parasite, either by its direct destruction or by increasing the capacity of the host to combat it. Nevertheless, studies by Da-Cruz et al. [15] demonstrated that the observed changes in the percentage of CD4 + and CD8 + T cells was a Leishmania specific response. In our work, the ex vivo study of CD4 + and CD8 + T cells of patients showed no significant difference, which was seen only after antigen stimulation-what suggests a specific stimulation by our antigen. The values observed ex vivo are, however, in agreement with the averages obtained by Autissier et al. [21] and Faria et al. [22] , suggesting that deleterious changes were not induced in patients after chemotherapy, as also implied in the study by Botelho et al. [23] .
Studies have shown that antigens from the promastigote forms of L. (V.) braziliensis, intact or sonicated, were able to induce different levels of cellular immune response [4] [5] [6] 12, [18] [19] [20] 25, 26, 31] and noted that the search for antigenic molecules is relevant for the identification of new subunit vaccine candidates and targets for immunotherapy. This reinforces the importance of our study inance of type 1 profile with IFN-c and TNF-a, however, still with production of Th2 cytokines. The PT patients showed similar results to the ones of SH, suggesting that this is an immunological profile associated with healing. In addition to reinforcing the importance of a type 1 immune response in the evolution for a healing and immunity from the disease, our work also showed that the presence of IL-10, an inhibitory cytokine, is essential as a counterbalance and control of an exacerbated immunopathology, a result also suggested by other groups [11, 19] . In studies with L. (V.) braziliensis it was found that in early ACL (<60 days) it is observed a preferential production of IL-10 and that there is a low or absent IFN-c production. This pattern then evolves into a predominantly Th1 cytokine profile, where patients have IFN-c production and lymphoproliferation [11, 27, 28] . Our results and those of other groups suggest that susceptible individuals after exposure to the parasite develop a type 2 immune response, allowing parasite survival and growth and the development of lesions. With the progression of the disease, this response changes to type 1 profile, activating macrophages, which leads to the control of parasite growth and disease progression. Therefore, it is possible that the development of the disease depends on a temporary immune dysregulation during the early stages of ACL [1, 5, 11] , since works correlate the participation of IL-10 and IL-4 with the evolution of ACL [27, 29, 30] .
Most patients with ACL heal after treatment with antimonials, which indicates a later development of an appropriate and beneficial immune response [7, 27, 28] . In the present study we saw that there was a significant increase in production of TNF-a and IFN-c in PT patients. It is interesting to note that SH patients had the same profile, with the production of TNF-a and IFN-c, even in the absence of chemotherapy. In endemic L. (V.) braziliensis areas spontaneously cured patients have been documented, showing this immune response profile even without treatment [7, 24] . This result reinforces the importance of the type 1 response, and demonstrates that it is necessary to control the multiplication and dissemination of Leishmania. Although there is no clinical or laboratory test to predict which patients will respond or fail to treatment with antimonials, it is likely that patients producing high levels of TNF-a and IFN-c have a better prognosis for cure in infections with L. (V.) braziliensis.
However, although a type 1 immune response is critical for the control of leishmaniasis, the loss of an appropriate modulation is responsible for the immunopathology [28] . In our study IL-10 production by CD4 + T lymphocytes in PT patients when stimulated with both antigenic fractions and by SH patients when stimulated with the soluble antigenic fraction, was not associated with a low production of IFN-c and TNF-a. This indicated a coordinated immunoregulation of T cells that produce protective and potentially pathogenic cytokines, a situation that leads to the resolution of the ACL infection. Therefore, as evidenced by our PT and SH patients, a proper balance between the responses that induce a leishmanicidal activity, those that induce the disease, and those that maintain the parasite persistence may be the most desired type of response against infection by L. (V.) braziliensis.
The immune pattern observed in the current study appears to be associated with the healing and/or protection in ACL, suggesting the existence of memory T cells and immunoregulatory mechanisms, whose function were triggered by our antigens. Patients' treatment can be beneficiated by immunological interventions if the exact role of T cells subtypes in the disease and resistance can be clarified [7, 12, 17, 29] . The immune response developed by patients against the antigens will be useful in determining an active disease prognosis and the necessary mechanisms for its evolution to cure. The observed result may also be an important parameter for future selection of antigens candidates for vaccine and prognostic tests, since the development and maintenance of a protective immune profile is very important and there is not yet a well defined antigen for the quest. This investigation adds informations to the search of factors that contribute to the susceptibility and putative protective immunity against human cutaneous leishmaniasis in L. (V.) braziliensis infection and provides additional information on the search for relevant antigens in this disease.
